BASF's Balance-Sheet Overhaul and Analyst Caution Collide as Shares Near 52-Week Peak
Published on 09/04/2026 at 07:10 | Editorial boerse-global.de
BASF's exit from the coatings business has crystallized into hard capital, with the €3.5 billion after-tax gain from the Carlyle deal now earmarked for debt reduction. The chemical giant plans to retire bonds and loans worth €1.6 billion in nominal volume during the third quarter of 2026, putting the divestment proceeds to work rather than letting them sit idle on the balance sheet.
The transaction, which closed at the end of June, received European Commission approval earlier that month under the condition that Carlyle offload Nouryon's global polysulfide operations. For BASF, the sale marks a clean break from a business line that no longer fits its core strategic focus — and the timing could hardly be better, as the company's core operations are simultaneously firing on all cylinders.
Pricing Power and Volume Growth Drive a Strong Quarter
Second-quarter results showed revenue climbing 16 percent to €17.2 billion, powered by an 11.5 percent increase in prices and a 7.3 percent gain in volumes. That combination of pricing strength and underlying demand is widely viewed in the chemicals sector as a more durable signal than price hikes alone, suggesting the uptick has genuine traction rather than being a purely inflationary artifact.
The earnings outlook for the full year was raised roughly a month ago, and the shares have added 5.7 percent since that revision. Notably, BASF left its free cash flow guidance unchanged at €1.5 billion to €2.3 billion — a sign that management is keeping cash flow projections conservative even as profit expectations improve. That prudence now looks well-placed, given that the upcoming €1.6 billion debt repayment will need to be funded without tapping external financing.
Managing the risks that come with running an industrial operation is just as important as the financial planning behind it. Many employers underestimate the compliance gaps that can surface when safety documentation isn't kept current. A free toolkit with 41 ready-to-use templates and checklists helps you document workplace hazards properly and stay on the right side of regulations. Download the free Risk Assessment Toolkit
A New Ludwigshafen Line Adds an Operational Milestone
Amid the financial engineering, BASF also marked a production milestone this week. On Wednesday, the company inaugurated a modernized facility for acid chlorides and chloroformates in Ludwigshafen. The investment, in the low triple-digit million euro range, expands capacity by roughly 30 percent while cutting the production site's average CO2 footprint by 19 percent. The plant has been running on green electricity certificates since 2025, underscoring the group's push toward lower-carbon manufacturing.
Analyst Sentiment Swings Back to Neutral
The operational progress hasn't gone unnoticed by the sell side, though the latest call is more measured. mwb research downgraded BASF to "Hold" in late August, citing a largely achieved fair value and persistent cash flow softness. But that rating action tells only part of the story: the same house had upgraded the stock from "Hold" to "Buy" as recently as July, following the better-than-expected quarterly numbers and the raised full-year guidance.
The downgrade therefore represents a return to a neutral stance after a meaningful share price run — not a fundamental shift in view on the underlying business. It's a valuation call, pure and simple: after weeks of gains, mwb research sees the stock's fair value as essentially reached, while questions around cash flow generation remain unresolved.
Industry Tailwinds — With a Caveat
The broader German chemicals landscape has been surprisingly supportive, though industry leaders warn against reading too much into the recent strength. The VCI chemical industry association reported second-quarter sales growth of 7.3 percent for Germany's chemical and pharmaceutical sectors, reaching €54.5 billion — the first increase in three years. Production rose 2.4 percent quarter-on-quarter, while producer prices climbed 5.7 percent.
The proximate cause appears to be geopolitical: the closure of the Strait of Hormuz amid the Middle East conflict has disrupted energy prices and weakened international competition, giving domestic producers an unusual boost. VCI President Markus Steilemann, however, cautioned that the uptick is "deceptive," with no genuine trend reversal in sight. Capacity utilization sits at 73.2 percent, well below the long-term average of 83 percent, and June already brought renewed declines in orders and revenues. For the full year, the VCI still expects production to contract by 1.5 percent, even as revenue rises 2.5 percent on price effects.
Shares Approach Their Peak
The stock closed Thursday at €53.36, just 3.1 percent below its 52-week high of €55.05 set in April. Year-to-date gains stand at 20 percent, with a 21 percent advance over twelve months. The shares trade comfortably above their 200-day moving average of €48.85, pointing to an intact medium-term uptrend.
Adding to the constructive picture is BASF's capital discipline. The €4 billion share buyback program launched in September 2024, running through the end of 2028, saw a new tranche of up to €1 billion approved just over a week ago. Between November 2025 and June 2026, the company had already repurchased shares worth roughly €1.5 billion.
For investors, the picture that emerges is one of a company methodically strengthening its financial foundation — shedding non-core assets, paying down debt, and returning capital — while its core business delivers solid growth. The main counterweight is analyst caution at current levels, with mwb research's move back to "Hold" reflecting a sense that much of the good news is already reflected in the price. Whether the stock can push through to its April high may depend less on the balance sheet story — which is now largely told — and more on whether the industry's recent momentum proves more durable than the VCI's own leadership expects.
